에 대한 최신 뉴스 Symbotic (NASDAQ:SYM) 주식

Symbotic

Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.

News

Movers

Trading Ideas

AFRM

ALAB

HOOD

MSTR

NCLH

SMCI

TSLA

UBER

지난주 가장 높은 성과를 보인 대형 주식 11개가 있다. 여러분의 포트폴리오에 포함되어 있나요? 1. 아스테라 랩스(NASDAQ:ALAB)의 주가는 인공지능(AI) 인프라를 위한 새로운 패브릭 스위치를 출시한 후 27.42% 상승했다. 주가 상승은 또한 분석가의 긍정적인 평가에서 기인했을 수 있다.

우버 및 로빈후드는 지난주 최고 성과를 보여준 11개 대형주 중 일부 (10월 7일-10월 11일)

Large Cap

CART

CRWD

CVNA

DUOL

INTC

MBLY

MSFT

지난주 연방준비제도(연준)가 금리를 50bp(베이시스 포인트) 인하하기로 결정하면서 기술, 건설, 산업, 기계 그리고 금융 부문 전반에 걸쳐 주가가 상승했다. 이들 11개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?

콘스텔레이션 및 카바나는 지난주 최고 성과를 보여준 11개 대형주 중 일부 (9월 16일-9월 20일)

COIN

DLTR

NBIX

OKTA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PSTG

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 달러 제너럴(NYSE:DG)의 주식은 회사가 2분기 실적과 매출이 예상보다 저조하게 나타났으며 2024년 가이던스를 하향 조정했다고 발표한 후 32.42% 하락했다. 많은 애널리스트들이 주가 목표를 하향 조정했다.

달러 제너럴 및 테무의 모회사 PDD는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (8월 25일-8월 31일)

Symbotic Inc

SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd

SymBio Pharmaceuticals Ltd

SYMPHONY INTERNATIONAL HOLDINGS ORD

SYMRISE ORD

Symbol

SYMBOLIC LOGIC INC by Symbolic Logic Inc.

Symbolic Logic Inc

SYMMETRY TECHNOLOGIES INC by Symmetry Technologies, Inc.

Symmetry Technologies Inc

SYMPHONY HOLDINGS ORD by Symphony Holdings, Ltd.

Symphony Holdings Ltd

SYMPHONY INTL HLDGS ORD by Symphony International Holdings Ltd.

Symphony International Holdings Ltd

Symrise AG

Tucker served as CFO of Jack in the Box Inc. from March 2018 to July 2020.

Management

JACK

Jack In The Box Reveals Return Of Lance Tucker As CFO, Effective January 13, 2025; Tucker Served As Its CFO From March 2018 To July 2020

Nuvei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEI#NASDAQ">NVEI</a>) reported quarterly earnings of $0.34 per share which missed the analyst consensus estimate of $0.50 by 32 percent. This is a 12.82 percent decrease over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $357.62 million which beat the analyst consensus estimate of $336.98 million by 6.12 percent. This is a 17.31 percent increase over sales of $304.85 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

NVEI

Nuvei Q3 Adj $0.34 Misses $0.50 Estimate, Sales $357.62M Beat $336.98M Estimate

RISES OVER 1.6% AT IT&#8217;S HIGH FOR THE DAY AFTER EARLY DROP AND THE POWER INFLOW SIGNAL
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="710" height="792" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/12211646/Screen-Shot-2024-11-12-at-4.13.02-PM.png" alt="" class="wp-image-3268" style="width:auto;height:450px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/12211646/Screen-Shot-2024-11-12-at-4.13.02-PM.png 710w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/12211646/Screen-Shot-2024-11-12-at-4.13.02-PM-269x300.png 269w" sizes="(max-width: 710px) 100vw, 710px" /></figure>
Eli Lilly &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:35 AM on November 12th, a significant trading signal occurred for Eli Lilly as it demonstrated a Power Inflow at a price of $816.14. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Lilly&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Lilly&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for LLY, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $816.14. The returns on the High price ($829.27) and Close price ($819.57) after the Power Inflow were respectively 1.6% and 0.4%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. 
Past Performance is Not Indicative of Future Results

Signals

Markets

Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal

Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) shares are moving higher in Tuesday&#8217;s after-hours session after the company announced the launch of its <a href="https://www.benzinga.com/pressreleases/24/11/b41919069/faster-leaner-more-efficient-rivian-and-volkswagen-group-announce-the-launch-of-their-joint-ventur">joint venture with Volkswagen Group</a>.
What Happened: Rivian and Volkswagen entered into a transaction agreement to create a new joint venture called &#8220;Rivian and VW Group Technology, LLC.&#8221; The deal has a total value of up to $5.8 billion and is expected to commence on Wednesday.
The joint venture will focus on providing next-generation electrical architecture and software technology for both companies&#8217; future electric vehicles across relevant vehicle segments.
Developers and software engineers from both companies are expected to join the joint venture. Teams will be based in Palo Alto, California, initially, with three other sites in development. Rivian&#8217;s Wassym Bensaid and Volkswagen&#8217;s Carsten Helbing will lead the joint venture as co-CEOs.
&#8220;Today&#8217;s finalization of our joint venture with Volkswagen Group marks an important step forward in helping transition the world to electric vehicles. We&#8217;re thrilled to see our technology being integrated in vehicles outside of Rivian, and we&#8217;re excited for the future,&#8221; said RJ Scaringe, founder and CEO of Rivian. 
Check This Out: <a href="https://www.benzinga.com/tech/24/11/41873064/tesla-rival-rivian-reports-steep-loss-of-about-40k-per-ev-in-q3-as-deliveries-hit-lowest-since-q1-2023">Tesla Rival Rivian Reports Steep Loss Of About $40K Per EV In Q3 As Deliveries Hit Lowest Since Q1 2023</a>
Rivian and Volkswagen expect to reduce development costs and scale new technologies more quickly through the joint venture. The joint venture aims to use existing Rivian architecture and software to enable the launch of Rivian&#8217;s R2 in the first half of 2026. The first models from Volkswagen supported by the joint venture are anticipated as early as 2027. 
Volkswagen has already invested $1 billion in convertible senior notes. The company will invest about $1.3 billion at the closing of the joint venture. Volkswagen plans to invest up to $5.8 billion by 2027.
Rivian is currently discussing the announcement on a <a href="https://rivian-special-call-webcast-2024.open-exchange.net/registration">call</a> with investors that kicked off at 5 p.m. ET. 
RIVN Price Action: Rivian shares were up 9.64% in after-hours, trading at $11.60 at the time of writing Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of Rivian.

Contracts

Tech

RIVN

Rivian Stock Races Higher After The Bell: What's Going On?

These collaborations aim to jointly advance plans and the first phase of execution for the development, testing, regulatory compliance, supply chain, and production planning of the two models.

FFIE

Faraday Future Subsidiary Faraday X Signs Definitive Agreements Relating To Two Planned Products With Top Original Equipment Manufacturers

Infrared Cameras Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.02) by 1600 percent. This is a 90.23 percent increase over losses of $(3.48) per share from the same period last year. The company reported $1.60 million in sales this quarter. This is a 6.87 percent increase over sales of $1.50 million the same period last year.

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

Infrared Cameras Holdings Q3 EPS $(0.34) Misses $(0.02) Estimate, Sales $1.60M Up From $1.50M YoY

Orla Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ORLA#AMEX">ORLA</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. The company reported quarterly sales of $99.31 million which beat the analyst consensus estimate of $80.39 million by 23.54 percent. This is a 64.70 percent increase over sales of $60.29 million the same period last year.

ORLA

Orla Mining Q3 2024 Adj EPS $0.06 Misses $0.08 Estimate, Sales $99.31M Beat $80.39M Estimate

NRDY

Nerdy Reveals Receipt Of Non-Compliance Notice From NYSE On November 12

Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.85) by 23.53 percent. This is a 53.9 percent increase over losses of $(1.41) per share from the same period last year.

CLDI

Calidi Biotherapeutics Q3 2024 GAAP EPS $(0.65) Beats $(0.85) Estimate

Occidental Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) reported its third-quarter results after Tuesday's closing bell. Here's a look at the key <a href="https://www.benzinga.com/pressreleases/24/11/g41919462/occidental-announces-third-quarter-2024-results">figures from the quarter. </a>
The Details:&nbsp;Occidental Petroleum reported quarterly adjusted earnings of $1.00 per share, beating the analyst consensus estimate of 74 cents. Quarterly revenue came in at $7.15 billion, missing the consensus estimate of $7.23 billion. 
<ul>
<li>Strong operational performance drove operating cash flow of $3.8 billion and operating cash flow before working capital of $3.1 billion.</li>
<li>Capital spending of $1.7 billion and contributions from noncontrolling interest of $47 million resulted in quarterly free cash flow before working capital of $1.5 billion.</li>
<li>Total company production of 1,412 Mboed exceeded the mid-point of guidance by 22 Mboed.</li>
<li>Midstream and marketing exceeded the mid-point of guidance for pre-tax adjusted income by $145 million.</li>
<li>OxyChem exceeded guidance with pre-tax income of $304 million.</li>
<li>Repaid $4 billion of debt, achieving nearly 90% of Occidental&#8217;s short-term debt reduction target.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/earnings/24/11/41914981/bitcoin-miners-hive-digital-hut-8-bitfarms-to-report-earnings-as-future-of-crypto-has-never-been-brighter">Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto &#8216;Has Never Been Brighter&#8217;</a>
&#8220;Strong operational performance across all segments has resulted in our highest quarterly operating cash flow this year,&#8221; said president and CEO Vicki Hollub. 
&#8220;The integration of CrownRock is off to a great start in terms of personnel and operations, and we have made significant progress in our deleveraging efforts, achieving nearly 90% of our short-term debt reduction target,&#8221; Hollub added. 
The company will host a conference call to discuss the results at 1 p.m. ET Wednesday.&nbsp;
OXY Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Occidental Petroleum shares are up 0.52% after-hours at $50.55 at the time of publication Tuesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Shutterstock

Commodities

After-Hours Center

Occidental Petroleum Shares Steady After Mixed Q3 Results

Oriental Culture Holding H1 EPS $(0.28) Up From $(0.50) YoY, Sales $0.447M Down From $0.799M YoY

Aris Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ARMN#AMEX">ARMN</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.14 by 42.86 percent. The company reported quarterly sales of $131.577 million which missed the analyst consensus estimate of $138.440 million by 4.96 percent. This is a 16.49 percent increase over sales of $112.955 million the same period last year.

ARMN

Aris Mining Q3 2024 Adj. EPS $0.08 Misses $0.14 Estimate, Sales $131.577M Miss $138.440M Estimate

Bolt Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLT#NASDAQ">BOLT</a>) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 14.29 percent. The company reported quarterly sales of $1.141 million which missed the analyst consensus estimate of $1.263 million by 9.64 percent. This is a 54.87 percent decrease over sales of $2.528 million the same period last year.

BOLT

Bolt Biotherapeutics Q3 2024 GAAP EPS $(0.40) Misses $(0.35) Estimate, Sales $1.141M Miss $1.263M Estimate

TERN

Terns Pharma Q3 EPS $(0.28) Beats $(0.34) Estimate

Guidance

GRDN

Guardian Pharmacy Services Sees FY24 Revenue $1.205B-$1.215B Vs $1.191B Estimate;  Sees Adj. EBITDA $86.5M-$87M

Guardian Pharmacy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRDN#NYSE">GRDN</a>) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $0.21 by 1052.38 percent. The company reported quarterly sales of $314.39 million which beat the analyst consensus estimate of $303.16 million by 3.71 percent. This is a 19.66 percent increase over sales of $262.74 million the same period last year.

Guardian Pharmacy Service Q3 2024 GAAP EPS $(2.00) Misses $0.21 Estimate, Sales $314.39M Beat $303.16M Estimate

Adams Resources &amp; Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AE#AMEX">AE</a>) reported quarterly losses of $(1.76) per share which missed the analyst consensus estimate of $(0.28) by 528.57 percent. The company reported quarterly sales of $695.163 million which beat the analyst consensus estimate of $654.996 million by 6.13 percent. This is a 8.61 percent decrease over sales of $760.614 million the same period last year.

Adams Resources & Energy Q3 2024 GAAP EPS $(1.76) Misses $(0.28) Estimate, Sales $695.163M Beat $654.996M Estimate

TeraWulf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) reported its third-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/g41918828/terawulf-reports-third-quarter-2024-financial-results">details from the report.&nbsp;&nbsp;</a>
The Details:&nbsp;TeraWulf reported quarterly GAAP losses of six cents per share, which missed the analyst consensus estimate for losses of three cents. Quarterly revenue came in at $27.05 million, which missed the analyst consensus estimate of $34.27 million and is an increase over sales of $18.95 million from the same period last year.
<ul>
<li>TeraWulf self-mined 555 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) across the Lake Mariner and Nautilus Cryptomine facilities, which represented a 43.4% decrease relative to the same quarter last year.</li>
<li>Total value of Bitcoin self-mined was $33.9 million compared to $27.6 million in the prior year&#8217;s quarter.</li>
<li>Power cost per Bitcoin self-mined increased year-over-year, to $30,448 per Bitcoin, up from $9,322 per Bitcoin in the third-quarter of 2023 due to an approximate doubling in network difficulty and the Bitcoin reward halving in April 2024.</li>
<li>Total self-mining hashrate capacity of 10.0 EH/s as of Sept. 30, 2024, represents an increase of 100% relative to the same prior year period.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/earnings/24/11/41914981/bitcoin-miners-hive-digital-hut-8-bitfarms-to-report-earnings-as-future-of-crypto-has-never-been-brighter">Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto &#8216;Has Never Been Brighter&#8217;</a>
&#8220;The third quarter and the beginning of the fourth quarter marked a pivotal turning point for TeraWulf, as we delivered strong results across our strategic, financial, and operational objectives,&#8221; said Paul Prager, chairman and CEO of TeraWulf.
&#8220;The sale of our interest in the Nautilus joint venture not only generated a substantial return but also sharpened our focus on scaling high-performance computing at Lake Mariner. Securing an expanded ground lease with exclusive rights to 750 MW of infrastructure capacity is a significant milestone in our growth strategy. Combined with the success of our $500 million capital raise, we are exceptionally well-positioned to seize new opportunities in both Bitcoin mining and HPC hosting as we enter 2025,&#8221; Prager added. 
WULF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, TeraWulf shares are down 3.51% after-hours at $8.23 at the time of publication Tuesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Pete Linforth from Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

WULF

TeraWulf Stock Tumbles After Worse-Than-Expected Q3 Results

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is unchanged from the same period last year. The company reported $7.92 million in sales this quarter. This is a 7.39 percent decrease over sales of $8.55 million the same period last year.

SunLink Health Systems Q1 EPS $(0.06), Same YoY, Sales $7.92M Down From $8.55M YoY

Cargo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) reported quarterly losses of $(0.88) per share which beat the analyst consensus estimate of $(1.15) by 23.48 percent. This is a 98.14 percent increase over losses of $(47.37) per share from the same period last year.

CRGX

Cargo Therapeutics Q3 EPS $(0.88) Beats $(1.15) Estimate

Symbotic Inc. falls after short report from Hunterbrook

Rocket Lab soars to top industrial gainer of week, Rentokil drops after profit warning

Powell Industries climbs to top industrial gainer of week, FedEx dips after earnings

A class action lawsuit was filed against Symbotic Inc. ($SYM) by Levi & Korsinsky on August 14, 2024. The plaintiffs (shareholders) alleged that th...

Class Action Lawsuit Against Symbotic Inc. (NASDAQ:SYM)

Analyst Hamed Khorsand from BWS Financial maintained a Sell rating on Symbotic (SYM – Research Report) and keeping the price target at $10.00. Hame...

Sell Rating on Symbotic Amidst Growth Deceleration and Revenue Recognition Concerns

In a report released today, Greg Palm from Craig-Hallum maintained a Buy rating on Symbotic (SYM – Research Report). The company's shares closed ye...

Craig-Hallum Sticks to Its Buy Rating for Symbotic (SYM)

Analyst Hamed Khorsand of BWS Financial maintained a Sell rating on Symbotic (SYM – Research Report), retaining the price target of $10.00. Hamed K...

Symbotic Faces Growth Challenges and Market Penetration Issues: A Sell Rating Analysis

Symbotic Has Plenty Of Room To Grow

Next Century Growth Investors Q3 2024 Commentary

Craig-Hallum analyst Greg Palm maintained a Buy rating on Symbotic (SYM – Research Report) today and set a price target of $0.00. The company's sha...

Craig-Hallum Keeps Their Buy Rating on Symbotic (SYM)

AAPL

ATEC

AVAV

CMPR

CRDO

CSWI

CWST

DXCM

FRPT

FTAI

GOOGL

IESC

KNSL

LOAR

MEDP

MRCY

NSSC

POWL

QTWO

RKLB

RXST

RYAAY

STRL

USAP

VCYT

Press Releases

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Symbotic

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Symbotic Inc. (SYM)

Legal

Shareholders that lost money on Symbotic Inc.(SYM) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Class Action Filed Against Symbotic Inc. (SYM) Seeking Recovery for Investors - Contact Levi & Korsinsky

SYM Investors Have Opportunity to Lead Symbotic Inc. Securities Fraud Lawsuit with the Schall Law Firm

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Symbotic

DEADLINE ALERT for EXTR, PDD, CXM, and SYM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Symbotic Announces Date for Reporting Fourth Quarter and Fiscal Year 2024 Financial Results

SYMBOTIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Symbotic Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Comments

Symbotic

뉴스

에 대한 최신 뉴스 Symbotic (NASDAQ:SYM) 주식

일요일, 10월 13, 2024

일요일, 9월 22, 2024

화요일, 9월 03, 2024

일요일, 8월 04, 2024

화요일, 7월 30, 2024

화요일, 5월 07, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌